Beyond the well-established role of Src kinases family in tumor initiation, progression and invasion, c-Src activation plays a key role also in the acquisition and maintenance of resistance to EGFR inhibitors in human lung, breast, colorectal and pancreatic cancer [84,85,86,87]. Here, SRC is linked to neoplasm.